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Antibodies have a well-established modular architecture wherein
the antigen-binding site residing in the antigen-binding fragment
(Fab or Fv) is an autonomous and complete unit for antigen
recognition. Here, we describe antibodies departing from this
paradigm. We developed recombinant antibodies to trimethylated
lysine residues on histone H3, important epigenetic marks and
challenging targets for molecular recognition. Quantitative char-
acterization demonstrated their exquisite specificity and high
affinity, and they performed well in common epigenetics appli-
cations. Surprisingly, crystal structures and biophysical analyses
revealed that two antigen-binding sites of these antibodies form
a head-to-head dimer and cooperatively recognize the antigen in
the dimer interface. This “antigen clasping” produced an expan-
sive interface where trimethylated Lys bound to an unusually
extensive aromatic cage in one Fab and the histone N terminus
to a pocket in the other, thereby rationalizing the high specificity.
A long-neck antibody format with a long linker between the anti-
gen-binding module and the Fc region facilitated antigen clasping
and achieved both high specificity and high potency. Antigen clasping
substantially expands the paradigm of antibody–antigen recog-
nition and suggests a strategy for developing extremely specific
antibodies.
antibody engineering | epigenetics | antibody validation |
protein–protein interaction | data reproducibility
The antigen-binding site of conventional immunoglobulins (Igs)is primarily composed of six complementarity-determining
regions (CDRs) located in the VH and VL domains (Fig. 1A).
Antibody fragments such as Fab and Fv are viewed as an au-
tonomous unit containing a single, complete site for antigen
recognition (1). The 1:1 stoichiometry of the antigen and Fab
(or Fv) is conserved among known antibody structures and
isotypes, including the “two-in-one” antibodies whose Fab spe-
cifically binds to two distinct antigens, but one at a time (2). This
paradigm has been a guiding principle in the engineering of di-
verse antibody formats such as bispecific antibodies (3).
The terminal regions of histone proteins (“histone tails”) are
unstructured and contain many posttranslational modification
(PTM) sites that are recognized by epigenetic regulatory machin-
eries involved in transcriptional regulation (4, 5). Antibodies to
histone PTMs are essential tools for epigenetics research, but
limited validation and large lot-to-lot variation of currently avail-
able anti-histone PTM antibodies are major sources of low
reproducibility (6–9). The challenge in achieving high specificity and
affinity can be reasoned by minute differences among chemical
moieties of PTMs, as small as a single methyl group, and sequence
similarity surrounding modification sites (e.g., those encompassing
H3K9 and H3K27) (SI Appendix, Fig. S1) and by the fundamental
challenge in recognizing flexible polypeptides due to unfavorable
entropic changes associated with binding. Highly specific recombinant
antibodies to histone PTMs, with their essentially infinite re-
newability, could fundamentally eliminate this major limitation (9).
The limited understanding of the molecular mechanisms un-
derlying the recognition of histone PTMs has severely limited
our ability to apply mechanism-based designs to the generation
of recombinant antibodies to a wider range of histone PTMs. For
example, it is unknown whether existing anti-histone PTM anti-
bodies and natural “reader” proteins use similar mechanisms.
Crystal structures of antibody–antigen complexes are critical
information for structure-guided design and engineering of an-
tibody affinity and specificity (2, 10). In this study, we isolated
highly specific and potent antibodies to trimethylated Lys4 and
Lys9 on histone H3 (abbreviated H3K4me3 and H3K9me3, re-
spectively) that are exquisitely specific, potent, and fully vali-
dated in standard epigenetics applications. Further, we describe
the crystal structures of both antibodies in complex with their
respective targets. Their structural and functional analyses revealed
an unprecedented mechanism of antigen recognition where two
antigen-binding sites cooperatively recognize one antigen.
Significance
Extensive studies of the structure–function relationship of
antibodies have established that conventional immuno-
globulins contain two copies of the antigen-binding frag-
ment (Fab), each of which serves as an autonomous and
complete unit for recognizing an antigen. In this paper, we
report a previously unidentified mode of antibody–antigen
recognition, dubbed “antigen clasping,” where two antigen-
binding sites cooperatively clasp one antigen, and the design
of a long-neck antibody format that facilitates antigen
clasping. Antigen clasping led to recombinant antibodies for
histone posttranslational modifications with extraordinarily
high specificity, valuable tools for epigenetic research. This
study substantially broadens the long-standing paradigm
for antibody–antigen recognition.
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Results
Generation of Recombinant Antibodies to Trimethylated Histone H3.
We generated recombinant antibodies to H3K4me3 and H3K9me3
by using directed evolution methods that mimic the processes
underlying the natural immune system: i.e., generation of low
affinity and specificity clones followed by maturation. We have
previously identified an antibody that weakly but specifically
recognizes trimethyl Lys, termed “clone 4-5”, from a naive
human antibody library (9). Then, we generated a single chain
Fv (scFv) phage-display library where we diversified a subset
of CDR residues (SI Appendix, Fig. S1) (9). After procedures
that led to our initial success in targeting H3K9me3 (9) that in-
volved rounds of stringent selection for specific binding to histone
peptides, we isolated new antibodies to H3K9me3 and H3K4me3,
termed 309M3-B and 304M3-B, respectively.
We then produced these antibodies in the form of Fab and
subjected them to extensive validation. They showed apparent
dissociation constants (KDs) of 2 nM and 11 nM to their cognate
peptide, respectively, as measured with the peptide immunopre-
cipitation (IP) assay (8). The reason for using the term “apparent” is
described in the next section. They had almost no detectable
binding to most other peptides tested, indicating high affinity
and exquisite specificity (Fig. 1 B and C). 309M3-B was more
sensitive to modifications of adjacent residues than our first
recombinant antibody to H3K9me3, termed 309M3-A, which
we reported previously (9), indicating that 309M3-B recognizes many
features of the H3K9me3 peptides outside the K9me3 site itself (SI
Appendix, Fig. S1). Similarly, 304M3-B preferentially recognized
unmodified forms of R2, T3, and T6 residues (SI Appendix, Fig.
S1). Characterization by IP-mass spectrometry (IP-MS) demon-
strated that both antibodies specifically enriched their cognate
targets from a mixture of synthetic peptides (Fig. 1D) (note that
the apparent enrichment of unmodified H3K4 and H3K9 was an
artifact due to experimental limitations) and from natural histone
extracts (SI Appendix, Fig. S2 and Table S1). The exquisite spec-
ificity of both antibodies was further validated by using internal
standard calibrated chromatin immunoprecipitation followed by
sequencing (ICeChIP) that allows quantitative assessment of spec-
ificity in the ChIP format using semisynthetic nucleosomes (11) (SI
Appendix, Fig. S2).
Both antibodies performed well in common epigenetics ap-
plications. They detected histone H3 in Western blotting of the
whole cell extracts, and, in the case of 304M3-B, the intense
histone H3 band was absent in the blot for the extracts from a
Set1-deleted yeast strain (SI Appendix, Fig. S3). In ChIP-seq of
HEK293 cells, 304M3-B produced sharp peaks localized in the
promotor regions and 309M3-B produced diffused peaks, and
their locations were mutually exclusive (Fig. 1 E and F, Left),
patterns consistent with the known distribution of these histone
PTM marks (9, 12, 13). As expected for recombinant proteins,
results using different batches of these antibodies were highly re-
producible (Fig. 1F, Right and SI Appendix, Fig. S3). Therefore,
these recombinant antibodies represent extensively validated, high-
performance tools for achieving accurate and reproducible results.
Formation of Head-to-Head Dimers That Sandwich the Antigen. Un-
expectedly, the binding properties of these antibodies differed
substantially, depending on the orientation of the IP assay (Fig. 2A
and SI Appendix, Fig. S4). In our standard IP assay, which mimics
the format of the standard immunoprecipitation method (8), a
biotinylated Fab is immobilized on streptavidin-coated beads first,
and a peptide captured by the antibody is quantified using flow
cytometry. In this format, we observed hyperbolic curves consis-
tent with a simple 1:1 binding model. Titrations in the reversed
orientation (i.e., soluble antibodies to a peptide immobilized on
beads) showed sigmoidal curves with a Hill coefficient substantially
Fig. 1. Exquisite specificity and high affinity of re-
combinant antibodies to H3K4me3 and H3K9me3.
(A) Schematic structure of the IgG. (B and C) Binding
titration curves of the 309M3-B (B) and 304M3-B
(C) antibodies to their cognate peptide and off-
target peptides measured with the peptide IP assay.
The calculated KD value to the cognate peptide is
shown. (D) Equal molar amounts of synthetic pep-
tides harboring different PTMs were mixed, and
then peptides were captured with 309M3-B (Top) or
304M3-B (Bottom) were quantified with MS. The
ratio to the input for each peptide is shown. *, The
apparent enrichment of unmodified peptides is
derived from enrichment of the input peptides
(residues 1–21) harboring H3K9me3 or H3K4me3
that also produce the peptides for H3K4un (residues
3–8) or H3K9un (residues 9–17), respectively, after
trypsin digestion. (E) Comparison of ChIP-seq data
at the same loci obtained with 304M3-B lot1 and
309M3-B lot1. (F) Scatter plots comparing the nor-
malized read densities (reads per base pair per
million mapped reads) for called peaks of the
dataset with 304M3-B and 309M3-B (Left) and with
different lots of 304M3-B (Right). The square of the
Pearson product-moment correlation coefficient (R2)
and the total number of peaks compared (N) are
indicated.
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greater than unity, indicating cooperating binding, and with much
higher half-saturation concentrations than those from the standard
format (Fig. 2A and SI Appendix, Fig. S4).
Strikingly, the crystal structures of 309M3-B and 304M3-B in
complex with peptides corresponding to their respective antigens
revealed that both antibodies formed head-to-head Fab dimers
(Fig. 2B and SI Appendix, Fig. S4). Two 309M3-B Fab molecules
bound one H3K9me3 peptide, with no internal symmetry
(Fig. 2B). Similarly, the 304M3-B Fab dimer bound two
H3K4me3 peptides, but with the two molecules related by an
approximately twofold rotational symmetry operation (SI Ap-
pendix, Fig. S4). In contrast, the crystal structure of 309M3-B in
complex with trimethylated Lys (i.e., a single amino acid without a
polypeptide chain) did not show dimerization, suggesting that its
dimerization requires peptide residues adjacent to trimethyl Lys
(SI Appendix, Fig. S4).
We then confirmed the occurrence of this unusual binding
mode in solution by using size-exclusion chromatography and dy-
namic light scattering. The sizes of the antibody–peptide complexes
were about twice as large as the antibodies alone (Fig. 2C and SI
Appendix, Fig. S5). A 2:1 molar ratio of antibody to peptide was
sufficient to fully induce the size shift of 309M3-B, whereas a 1:1
ratio was required for 304M3-B. The binding stoichiometries in
solution are consistent with those observed in crystals. Also
consistent with the crystal data, trimethyl Lys did not induce the
size shift of 309M3-B (SI Appendix, Fig. S5). These results conclu-
sively demonstrated antigen-induced dimerization of 309M3-B and
304M3-B. We term this mode of antigen recognition “antigen
clasping” hereafter.
Anti-peptide or anti-small compound antibodies typically have a
deep cleft created by long CDRs (14, 15) (SI Appendix, Fig. S6). In
contrast, the antigen-binding sites of our antigen-clasping anti-
bodies are flat, consistent with their short CDRs (Fig. 3A and SI
Appendix, Fig. S6), a topography similar to that found for antibodies
to large spherical antigens such as structured proteins. Antigen
clasping by two copies of a flat antigen-binding site created large
interaction surfaces. The interfaces (1,177 Å2 for the H3K9me3
peptide and 987 Å2 for the H3K4me3 peptide) (SI Appendix,
Table S2) were nearly twice as large as typical peptide–protein
binding interfaces (16). 309M3-B used a total of 8 CDRs to rec-
ognize the H3K9me3 peptide, and, remarkably, 304M3-B used 12
CDRs (i.e., all CDRs available in the Fab dimer) in binding to two
H3K4me3 peptide molecules (Fig. 3A and SI Appendix, Fig. S6).
Therefore, antigen clasping enables antibodies to use most CDRs
and create large interacting surfaces, leading to high affinity and
specificity toward peptide antigens.
Recognition of Trimethylated Lys and Histone N Terminus with Two
Distinct Pockets. Close inspection of the antibody–peptide inter-
faces revealed two common features between the two structures.
First, there is an “aromatic cage” located at the interface between
the heavy and light chains that perfectly fit the trimethylated qua-
ternary ammonium cation of Lys Ne (Fig. 3 B and D and SI Ap-
pendix, Fig. S6). Aromatic cages are known binding pockets for
methylated Lys moieties in natural histone reader proteins, in which
methylated ammonium groups interact with the aromatic side
chains mediated by the cation–π interaction (17, 18). The aromatic
cage in our antibodies is more extensive and optimal for trimethy-
lated Lys than natural counterparts, rationalizing the much higher
ability of our antibodies to distinguish trimethylated Lys from
dimethylated Lys (SI Appendix, Fig. S7). Interestingly, Arg8 of
the H3K9me3 peptide fit in the aromatic cage in the second
Fab molecule and made electrostatic interactions with acidic
residues located at the base of the cavity (Fig. 3B). Occupation
of an aromatic cage by the Arg side chain has been observed for the
SET domain of Ezh2 (19), suggesting that aromatic cages have
inherent affinity to Arg.
Second, a binding pocket formed by residues in CDRL1 and
L2 recognized the N-terminal two residues (Ala1 and Arg2) of
the histone (Fig. 3 B and C and SI Appendix, Fig. S6). Mutation
Fig. 2. Cooperative dimerization of two antigen-binding sites. (A) Effects of
the assay orientation on the binding reactions of 309M3-B. (Top) Scheme and
titration of a soluble peptide to immobilized antibodies: i.e., the standard IP
assay. (Bottom) Scheme and titration in the reversed orientation where a
soluble Fab protein is added to immobilized peptide. The titration data in the
Top panel is the same as that shown in Fig. 1B. The curves show the best fit
of the Hill equation, with the values of the Hill coefficient, α, indicated. Note
the different concentration ranges on the horizontal axis. Data shown are
from triplicate measurements. (B) The overall structures of 309M3-B in com-
plex with the H3K9me3 peptide. The scheme depicts the binding mechanism
of the 309M3-B antibody that forms asymmetric homodimerization with the
H3K9me3 peptide. The heavy and light chains in Fab 1 are shown in red and
pink, respectively, and those in Fab 2 (the dimerization partner of Fab1) are
shown in blue and cyan, respectively. (C) Dimerization of 309M3-B in solution
analyzed using gel filtration chromatography (graph) and dynamic light
scattering (table). The Fab sample was mixed with the peptides with the in-
dicated ratios and analyzed. Arrows indicate the peak positions of calibration
proteins (γ-globulin, ovalbumin, and myoglobin, from left to right). The
complete dataset for dynamic light scattering is in SI Appendix, Fig. S5.
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studies confirmed the importance of both the aromatic cage and
A1R2-binding pocket for antigen recognition (Fig. 3 C and D and
SI Appendix, Figs. S6 and S8).
Antigen Clasping Enables Fine Control of the Distance Between the
Two Pockets. Remarkably, the peptides bound to the A1R2-binding
pocket in one Fab and to the aromatic cage in the other in both
structures, thereby bridging the two Fab molecules across the dimer
interface (Fig. 3 A and B and SI Appendix, Fig. S6). We confirmed
this binding mode by constructing an active heterodimer with two
complementary “half-site” mutants, one containing a mutation in the
aromatic cage and the other containing a mutation in the A1R2-binding
pocket (Fig. 4A). Although the homodimers containing mutation in the
aromatic cage (Y58HA) or in the A1R2-binding site (D51LA/D53LA)
were inactive, the heterodimer of the two mutants regained binding.
Together, these features rationalize the unusual cooperative binding and
high functionality of these antibodies.
304M3-B and 309M3-B achieved their high sequence speci-
ficity to different Kme3 marks using a set of common recognition
motifs: i.e., the aromatic cage and the A1R2-binding pocket. Curi-
ously, although these motifs are conserved in these antibodies (and
the starting clone) because we did not mutate residues forming
these pockets (SI Appendix, Fig. S1), their sequence specificity
profiles are essentially mutually exclusive (Fig. 1 B and C). Super-
position of the two structures revealed a large difference in the
relative position of the two Fab molecules (Fig. 4B), with a con-
comitant alteration in the spacing between the aromatic cages
and the A1R2-binding pockets. The span between the two pockets
seems optimal for the H3K9me3 peptide in the 309M3-B complex
(∼20 Å) and for the H3K4me3 peptide in the 304M3-B complex
(∼7 Å), but much too short for other major Lys modification sites
(e.g., H3K27, H3K36, and H4K20) (Fig. 4B), explaining their spec-
ificity profiles. Likewise, the need for optimizing the distance between
the two pockets rationalizes why the peptide is bound across two Fab
molecules because this distance within a single Fab molecule (∼13 Å)
is invariant and too large for H3K4me3 and too small for H3K9me3.
Therefore, we propose that the dimerization and the strategically
positioned two recognition motifs in these antibodies play important
roles in highly specific recognition of the histone marks.
The structures suggest that antigen clasping is obligatory for
these antibodies to achieve high affinity and high specificity.
Mutation of a single residue (two for the Fab dimer) in the Fab–
Fab interface abolished antigen binding, indicating the impor-
tance of this contact in achieving the observed mode of peptide
recognition (Fig. 4C and SI Appendix, Fig. S9). Interestingly, the
ability to form a peptide-induced dimer emerged in the directed
evolution process. The Fab–Fab contacts in the two antibodies
are different and involve residues in CDRH2 that were altered with
respect to the starting clone (Fig. 4C and SI Appendix, Fig. S9). In
contrast to these two antibodies, the previously developed anti-
body for H3K9me3, 309M3-A, did not exhibit antigen clasping
although it was isolated from the same phage-display library and it
differs in only 10 CDR positions from 309M3-B (SI Appendix,
Figs. S1 and S5). It is notable that mutations required for antigen
clasping are within CDRs, regions that are highly varied in natural
antibodies, suggesting that these antibodies and other yet-to-be-
identified dimerizing Fab molecules could exist in the natural
immune system.
A “Long-Neck” Format Promotes Antigen Clasping.We then designed
an antibody format, termed “long-neck antibody,” to facilitate
antigen clasping. We reasoned that the format of our phage
Fig. 3. Recognition of a single H3K9me3 peptide at
the interface of two antigen-binding sites. (A) In-
teractions of the H3K9me3 peptide with the Fab
dimer. (Center and Right) The peptide-recognition
interface in an open book manner. CDRs that in-
teract with the peptide are labeled in yellow. (Right)
Key elements in Fab1 and Fab2. (B) Details of the
antibody–peptide interaction interface. The amino
acid residues are colored in the same manner as in
Fig. 2B. Peptide residue numbers are in red. The
A1R2-binding pocket and the aromatic cage are
enclosed in a gray shade. Polar interactions are
marked as dashed lines. Residues mutated with re-
spect to the lead antibody, 4-5, are labeled in blue.
(C) A close-up view of the recognition of the A1R2
motif with its binding pocket in 309M3-B (Left). The
D51LA/D53LA double mutant abolishes binding as
tested with the peptide IP assay (Right). (D) The ar-
omatic cage in 309M3-B. (Left) The side chains that
create the aromatic cage and trimethylated Ne of
Lys9. (Right) The effects of alanine mutations of
these residues tested with phage ELISA. Binding data
shown here are from triplicate measurements. See SI
Appendix, Fig. S8 for additional data.
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display system, where scFv molecules are tethered to a phage coat
protein via a long linker, enabled us to identify these unusual
antibodies. Thus, we connected an antigen-binding module (scFv
in this case) to Fc with a 17-residue linker (Fig. 5A). We chose
scFv over Fab because the use of Fab would require a much
longer linker. As expected, the long-neck scFv-Fc antibodies
did not show cooperativity in the reversed IP assay, demonstrating
that this format promotes antigen clasping within a single antibody
molecule (Fig. 5B and SI Appendix, Fig. S10). In contrast, the
same antigen-binding sites in the standard IgG format showed
weaker binding and strong cooperativity. The long-neck scFv-Fc
antibodies worked well in Western blotting and immunostaining
analyses at high dilutions (SI Appendix, Fig. S10), further sup-
porting the potency of the long-neck scFv-Fc format.
Discussion
In this study, we generated recombinant antibodies to H3K4me3
and H3K9me3 that performed well in epigenetics applications,
successfully determined the crystal structures of antibody–peptide
complexes, and elucidated how these antibodies achieved high
specificity and high affinity to challenging targets, histone tails
containing Kme3 marks. These highly validated recombinant
antibodies, as well as future recombinant antibodies engineered
based on the mechanistic insights gained in this work, will pro-
vide the epigenetic research community with a set of standard
reagents that will improve data accuracy and reproducibility.
Antigen clasping is highly unusual among known antibody
structures. Dimerization of Fab molecules in crystals is observed
in cases where the antigen itself has internal twofold symmetry,
as expected (20, 21), but histone peptides described here do
not form dimers or have internal symmetry. Antigen clasping is
also distinct from the binding mode of the bispecific, chelating
recombinant antibody (CRAb) because a CRAb is constructed
by linking two different scFv molecules (22) and the two scFv
units bind to nonoverlapping epitopes of a protein. Among ∼1,200
structures of antibody–antigen complexes in the Protein Data
Bank, we found a single example, anti–C-myc antibody 9E10,
that seems to exhibit antigen clasping. However, the binding
mode of 9E10 conforms to the convention of anti-peptide an-
tibodies because one Fab dominates peptide recognition by
capturing the peptide into a deep cleft created with long CDRs,
and this antibody showed no cooperative binding (23). By
contrast, in our antibodies, two Fab molecules synergistically
contribute to peptide recognition. Nevertheless, the 9E10 struc-
ture supports the view that natural antibodies have an inherent
capacity to clasp an antigen.
What factor restricts the immune systems from producing
antibodies exhibiting antigen clasping? Or have such antibodies
been simply overlooked because the existing paradigm of anti-
body–antigen interaction is so well established? In conventional
antibodies, two Fab segments are connected with disulfide bonds
in the hinge region located between the Fab and Fc regions
(Fig. 1A). This architecture makes the antigen-binding sites in
the two Fab regions face opposite directions to each other. The
distance between the C termini of two Fab molecules in IgG
(∼15 Å between the C termini of the CH1 domains) (Fig. 1A) is
much too short for forming a head-to-head dimer (∼120Å) (Fig.
2B) (24, 25). Thus, it is sterically difficult for the two Fab arms of
a single IgG molecule to form a head-to-head dimer. Indeed,
309M3-B in the IgG format still shows cooperative binding with
low affinity in the reverse IP assay, indicating dimer formation
between two IgG molecules (Fig. 5 A and B). Such intermo-
lecular dimerization leads to low efficacy, diminishing the likelihood
of isolating this type of antibodies. Uncontrolled interaction be-
tween antigen-binding sites may promote aggregation, perhaps
leading to low probability of generating functional antibodies.
In addition to the geometrical restrictions described above, a
clasping antibody requires a single antigen-binding unit with
Fig. 4. Structural basis for the exquisite sequence specificity of the
antibodies. (A) Two complementary half-site mutants retained antigen-
binding function by forming a heterodimer. The addition of the 309M3-B
A1R2-binding site mutant to yeast cells expressing the 309M3-B aromatic
cage mutant resulted in “heterodimer” formation only in the presence of
H3K9me3 peptide. The binding of the peptide was detected in the same
manner as the peptide IP assay. (B) Superposition of 309M3-B (dark pur-
ple) and 304M3-B (gray) using the variable domains of Fab 1 as the
common element (Left). Only the variable domains are shown for clarity.
The H3K9me3 and H3K4me3 peptides are shown as stick models in red
and yellow, respectively. Only one molecule for H3K4me3 peptide is
shown for clarity. (Right) A comparison of the bound peptides using
superposition of the aromatic cages. The aromatic cages of 304M3-B
and 309M3-B are shown in light and dark green, respectively, and resi-
dues in the A1R2-binding pockets are shown in magenta. A1, R2,
and trimethylated lysine residues in the H3K4me3 peptide are shown in
orange, and their counterparts in the H3K9me3 peptide are shown
in yellow. The Cα atoms of the R2 and Kme3 residues are shown as
spheres, and the distances between these atoms in the two peptides
are indicated. (C ) Antibody–antibody contacts between two 309M3-B
molecules. Polar interactions are marked as dashed lines. The color
scheme is the same as in Fig. 2B. The residues that are different from
clone 4-5 are labeled in blue. See SI Appendix, Fig. S9 for more detail.
Mutation of D53H abolishes antigen biding as tested with the peptide IP
assay (Right).
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binding interfaces that recognize different parts of the peptide,
as well as the antibody/antibody contacts that are not ener-
getically unfavorable. These considerations rationalize why
antibodies exhibiting antigen clasping are rare.
Whereas generation of homodimeric clasping antibodies like
those reported here may be challenging, one can envision con-
structing clasping antibodies with two different antigen-binding
units. One could iteratively engineer a first unit binding to the
antigen and then a second unit binding to the complex of the first
unit and the antigen to achieve clasping. Indeed, our group has
generated a class of synthetic binding proteins termed “affinity
clamps” by using a natural peptide-binding domain as the first unit
and a synthetic binding protein (“monobody”) as the second unit
(26). The successes of affinity clamp engineering (26, 27) support
the feasibility of generating heterodimeric clasping antibodies.
This study has expanded the paradigm for antibody–antigen
recognition and identified an evolutionary restriction contribut-
ing to the rarity of antibodies that form Fab dimers. Antigen
clasping doubles the size of the antigen recognition interface and
allows for the formation of extensive interactions that completely
surround a small antigen. We anticipate that antibody formats en-
abling antigen clasping (e.g., the long-neck format) and iterative
selection strategies will have a strong impact on unleashing mo-
lecular recognition potentials of antibodies toward currently chal-
lenging targets, including histone PTMs and small compounds.
Materials and Methods
Selection, purification, and characterization of recombinant antibodies to
histone PTMs were performed essentially as described previously (9). IP-MS,
ICeChIP, and ChIP-seq were performed following published methods (11, 28,
29). Further details on the materials and methods used in this study are
described in SI Appendix.
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Fig. 5. An antibody format that promotes head-to-head dimerization. (A)
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of the Hill coefficient, α, indicated. All binding data shown here are from
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